Evidence map›Paper›PMID 32820258›Full record

ArticleNature genetics2020

Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.

Brett S Carver, Jennifer Tran, Anuradha Gopalan, Zhenbang Chen, Safa Shaikh, Arkaitz Carracedo, Andrea Alimonti, Caterina Nardella, Shohreh Varmeh, Peter T Scardino and 3 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Brett S CarverCancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA.
Jennifer TranCancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA.
Anuradha GopalanDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Zhenbang ChenCancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA.
Safa ShaikhDepartment of Surgery, Division of Urology, New York, New York, USA.
Arkaitz CarracedoCancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA.
Andrea AlimontiCancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA.
Caterina NardellaCancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA.
Shohreh VarmehCancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA.
Peter T ScardinoDepartment of Surgery, Division of Urology, New York, New York, USA.
Carlos Cordon-CardoDepartment of Pathology, Columbia University, New York, New York, USA.
William GeraldDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Pier Paolo PandolfiCancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA. ppandolf@bidmc.harvard.edu.
Kettering University · USBeth Israel Deaconess Medical Center · USMemorial Sloan Kettering Cancer Center · USColumbia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32820258
OpenAlexW3050784375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.